Ketamine’s reputation has come a long way since it entered the public sphere in the 60s. In the decades since its inception, ketamine has commanded attention and respect throughout the medical industry for its profound impact on depression and anxiety. Now, the public at large is beginning to recognize it as a viable treatment for mental health conditions. But despite an abundance of research and medical support, a few outdated misconceptions persist.
Hudson Mind’s Dr. Marcel Green recently spoke to Healing Maps about the biggest misconception he hears from patients who are new to psychedelic therapy:
A common misconception about ketamine is that its benefits are purely experiential. When, in fact, ketamine activates significant physiological changes in the brain. We know that major stress and depression can change the composition of a brain, weakening synaptic connections that make it more difficult for regions of the brain to communicate. Low-dose ketamine treatments restore these dormant neural circuits by triggering the production of Glutamate, which in turn, promotes BDNF, a protein that encourages neuroplasticity in the brain.
To learn more about the facts behind the most common ketamine myths, check out The Biggest Misconceptions About Ketamine Therapy on Healing Maps.
